BioPlus Acquisition Corp.

BIOSNASDAQFinancial Services

$10.80

$-0.01(-0.05%)

Market Cap$209072163

P/E Ratio—

52W High$11.68

52W Low$10.12

Avg Volume37K

Open$10.80

Beta0.00

Free Cash Flow Financials Revenue

BioPlus Acquisition Corp. (BIOS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

BIOS · free cash flow · updated Jun 9, 2026

Core FCF metrics

BIOS · FCF · TTM · margin & CAGR

Free cash flow was −$691,465 for FY2022 (fiscal year ending 2022-12-31)

FY2022 Free Cash Flow−$691,465▼ -81798.5% YoY

Trailing 12M (TTM)−$1.6Mtrailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

BIOS · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2022Latest−$691,465(0M)−$691,465▼ 81798.5%—

FY2021−$844.295(0M)−$844.295▲ +100.0%—

FY2018−$20.1M(14M)−$34.0M▼ 260.0%-4.8%

FY2017−$760,000(9M)−$9.4M▲ +82.0%-1.2%

FY2016−$42.8M(10M)−$52.4M▲ +31.3%-5.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

BIOS · P/FCF · FCF yield · FCF per share

BioPlus Acquisition Corp. (BIOS) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2022 · 2022-12-31

Cash flow statement summary

BIOS · cash flow statement · operating / investing / financing

For FY2022, BioPlus Acquisition Corp. generated −$0.7M in operating cash flow and spent 0M in capital expenditures, yielding −$0.7M in free cash flow.

Operating Activities

−$0.7M

Cash from core business operations

2022-12-31

Investing Activities

+$0.0M

CapEx, acquisitions & investments

2022-12-31

Financing Activities

+$0.2M

Buybacks, dividends & debt

2022-12-31

FCF FormulaOperating CF (−$0.7M) − |CapEx| (0M) = FCF (−$0.7M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Financial Services)

BIOS vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

BioPlus Acquisition Corp.YOU

BIOS

−$691,465-81798.5%—

Loss

Berkshire Hathaway Inc.

BRK-B

$25.04B+115.6%6.7%

25%

Berkshire Hathaway Inc.

Mastercard Incorporated

$16.91B+18.2%51.6%

17%

Financial Services · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

BioPlus Acquisition Corp. (BIOS) reported free cash flow of −$691,465 for FY2022 (fiscal year ending 2022-12-31).

Based on available data, BioPlus Acquisition Corp. has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $26.5M in FY2011.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

BIOS free cash flow · 8 questions

BioPlus Acquisition Corp. free cash flow was −$691,465 for FY2022. On a trailing twelve-month (TTM) basis, free cash flow stands at −$1.6M.

BIOS free cash flowBIOS FCFBIOS FCF 2022BIOS free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · BioPlus Acquisition Corp. · BioPlus Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026